/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Mind Medicine (MindMed) Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$12.18 -0.01(-1%) MNMD at 04 Dec 2025 04:38 PM Biotechnology
Lowest Today 11.925
Highest Today 12.41
Today’s Open 12.18
Prev. Close 12.06
52 Week High 14.43
52 Week Low 4.70
Day’s Range: Low 11.925 High 12.41
52-Week Range: Low 4.70 High 14.43
1 day return -
1 Week return -5.65
1 month return -0.58
3 month return +29.25
6 month return +55.94
1 year return +59.06
3 year return +321.55
5 year return -
10 year return -

Institutional Holdings

BlackRock Inc 7.63

COMMODORE CAPITAL LP 6.57

Blackstone Inc 4.71

Marshall Wace Asset Management Ltd 4.50

Driehaus Capital Management LLC 4.06

Deep Track Capital, LP 3.29

Octagon Capital Advisors LP 2.80

iShares Russell 2000 ETF 2.41

Vanguard Group Inc 2.38

State Street Corp 2.37

Geode Capital Management, LLC 2.28

Awm Investment Company Inc 1.60

Fidelity Small Cap Index 1.00

Vanguard Institutional Extnd Mkt Idx Tr 0.97

Ally Bridge Group (NY) LLC 0.95

Heptagon Driehaus US Micro Cap Eq C$ Acc 0.92

Morgan Stanley - Brokerage Accounts 0.90

TANG CAPITAL MANAGEMENT LLC 0.79

Northern Trust Corp 0.79

Charles Schwab Investment Management Inc 0.79

UBS Group AG 0.68

Woodline Partners LP 0.66

iShares Russell 2000 Value ETF 0.61

Rosalind Advisors, Inc. 0.55

Fidelity Extended Market Index 0.49

Vanguard Russell 2000 ETF 0.47

Schwab US Small-Cap ETF™ 0.43

Driehaus Micro Cap Growth USD 0.36

Driehaus Micro Cap Growth USD 0.36

State St Russell Sm Cap® Indx SL Cl I 0.35

Wellington Management Company LLP 0.34

iShares Russell 2000 Growth ETF 0.28

SPDR® S&P Pharmaceuticals ETF 0.28

Schwab Small Cap Index 0.25

Vanguard Health Care ETF 0.24

iShares US Pharmaceuticals ETF 0.24

NT R2000 Index Fund - NL 0.24

iShares Micro-Cap ETF 0.22

NT R2000 Index Fund - DC - NL - 3 0.19

Extended Equity Market Fund K 0.18

Market Status

Strong Buy: 7

Buy: 4

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 1172.46 M

PB Ratio 9.542

PE Ratio 0.0

Enterprise Value 1077.46 M

Total Assets 302.15 M

Volume 1319127

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:null 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-76771000 -76.8M, FY22:-47261000 -47.3M, FY21:-93036000 -93.0M, FY20:-34101000 -34.1M, FY19:-1225725 -1.2M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-67265000 -67.3M, Q2/2025:-42744000 -42.7M, Q1/2025:-23348000 -23.3M, Q3/2024:-13684000 -13.7M, Q2/2024:-5854000 -5.9M

Fund house & investment objective

Company Information Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Organisation Biotechnology

Employees 74

Industry Biotechnology

CEO Mr. Robert Barrow

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow